Search hospitals > Pennsylvania > Sayre

Guthrie Medical Group PC-Robert Packer Hospital

Claim this profile
Sayre, Pennsylvania 18840
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
137 reported clinical trials
6 medical researchers
Photo of Guthrie Medical Group PC-Robert Packer Hospital in SayrePhoto of Guthrie Medical Group PC-Robert Packer Hospital in Sayre

Summary

Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 246 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.

Area of expertise

1Skin Cancer
Global Leader
Guthrie Medical Group PC-Robert Packer Hospital has run 53 trials for Skin Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Guthrie Medical Group PC-Robert Packer Hospital has run 32 trials for Breast Cancer. Some of their research focus areas include:
ER positive
Stage IV
PR positive

Top PIs

Clinical Trials running at Guthrie Medical Group PC-Robert Packer Hospital

Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Cancer
Ovarian Cancer
Pancreatic Cancer
Uterine Tumors
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Guthrie Medical Group PC-Robert Packer Hospital?
Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 246 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security